Researchers pave the way for improving treatment for Type 2 diabetes

February 7, 2012

In a study published last week in the prestigious Proceedings of the National Academy of Sciences of the United States of America, a team led by Dr. Vincent Poitout of the University of Montreal Hospital Research Centre (CRCHUM)* has made an important step forward in understanding how insulin secretion is regulated in the body. This discovery has important implications for drugs currently in development to treat Type 2 diabetes, a disease which is diagnosed every 10 seconds somewhere throughout the world.

Poitout's team studies the G protein-coupled free fatty acid receptor (FFA1/GPR40), a molecule that plays a key role in stimulating and regulating the production of insulin, a hormone produced by the pancreas to remove excess glucose from the blood, which otherwise would be toxic.

Poitout's team demonstrated that glucose in the blood stimulates the expression of the receptor, which in turn prompts the body to produce insulin when glucose and rise in the circulation, such as occurs after a meal. Their accomplishment consists in mapping the intricate pathway taken by glucose to stimulate the expression of the receptor and in identifying the various genetic and cellular processes which are activated in this process. This phenomenon contributes to maintaining the right balance between the intake of nutrients and the production of insulin. That balance is precisely what is upset in patients, for whom the production of insulin is deficient, and which leads to a variety of chronic conditions.

Although a new generation of antidiabetic drugs which target this receptor to promote insulin tolerance and production is currently being tested, until now little has been known about precisely how the expression of GPR40 is controlled. "Our work has contributed to a better understanding of how these new drugs work. Our ultimate goal is to allow type 2 to lead a healthy life free from the many complications associated with this disease," explains Poitout.

Type 2 diabetes, which used to occur as people grew older, now appears at a younger age due to the increasing prevalence of obesity in children and adolescents. Its appearance can be hastened by an unhealthy lifestyle (fat-rich diet, lack of exercise, etc.). Although it can sometimes be controlled by adopting a healthier lifestyle and diet, most patients are required to take daily medication for the rest of their lives. The prevalence of diabetes is expected by the World Health Organization to exceed 550 million people by 2030.

Explore further: Saturated fatty acids lead to mitochondrial dysfunction and insulin resistance

Related Stories

Recommended for you

Which diabetes drug is best?

July 19, 2016

(HealthDay)—No single drug to treat type 2 diabetes stands out from the pack when it comes to reducing the risks of heart disease, stroke or premature death, a new research review finds.

Gut bacteria imbalance increases diabetes risk

July 13, 2016

Currently, scientists think the major contributors to insulin resistance are excess weight and physical inactivity, yet ground-breaking new research by an EU funded European-Chinese team of investigators called MetaHit have ...

Team explores genetic architecture of type 2 diabetes

July 11, 2016

New research from a large international team of scientists offers a more complete picture of the genes responsible for type 2 diabetes, demonstrating that previously identified common alleles shared by many in the world are ...

Normal weight may not protect against diabetes

July 14, 2016

(HealthDay)—Type 2 diabetes has long been considered a disease of the overweight and obese, but a new study challenges that notion. It finds nearly one in five normal-weight people has prediabetes—a condition that can ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.